Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 May 13;11(6):ofae265. doi: 10.1093/ofid/ofae265

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

PMC Copyright notice

Figure 1. — Appeal of long-acting injectable cabotegravir/rilpivirine administered out-of-clinic by oneself or a partner/friend/family member among US persons with human immunodeficiency virus (N = 370) across 3 urban clinics overall (top panel; stratified by self-administration or partner/friend/family administration). Separately, appeal of receiving injections administered by oneself (bottom left panel) or a partner/friend/family member (bottom right panel) by individual site (San Francisco, Chicago, or Atlanta).